For instance, in breast cancer, the upregulation of miR-152-3p exerts its antitumor role by negatively regulating PIK3CA to suppress the activation of AKT and RPS6, thus inhibiting the HCC1806 cell proliferation 23. This evidence concerns the gene AKT1 and breast carcinoma.